Sovaldi (Sofosbuvir)

This is an antiviral medicine used to treat Hepatitis C. It helps your body fight off the virus that causes this liver infection. It's often taken with other medications.

Brand names:Sovaldi
Medication

What people taking Sovaldi (Sofosbuvir) report

Every report comes from a Lived member, sent anonymously.

Have you tried Sovaldi (Sofosbuvir) for Hepatitis C?

NameHow it went

About Sovaldi (Sofosbuvir)

What It's For

Sofosbuvir, sold alone as Sovaldi, is an antiviral medicine for chronic hepatitis C, a long-lasting infection with the hepatitis C virus that can slowly scar the liver over years and lead to cirrhosis or liver cancer. Treatment aims to clear the virus from the body, which is considered a cure. Sofosbuvir is never used by itself. Sovaldi is approved for adults with hepatitis C genotypes 1 through 4 (genotypes are strains of the virus) who have no cirrhosis or only compensated cirrhosis, meaning the liver is scarred but still working. It is given with ribavirin, another antiviral, and for genotypes 1 and 4 also with peginterferon, an injected medicine. It is also approved, with ribavirin, for children 3 and older with genotype 2 or 3. Today most people who take sofosbuvir get it inside a combination tablet instead. Epclusa (sofosbuvir with velpatasvir) treats all six genotypes in adults and children 3 and older, and is one of two first-line regimens in US treatment guidance. Harvoni (ledipasvir with sofosbuvir) treats several genotypes, and Vosevi (sofosbuvir, velpatasvir and voxilaprevir) is mainly for people whose earlier treatment did not cure them. These products contain different partner drugs and are not interchangeable.

How It Works

The hepatitis C virus copies itself inside liver cells using an enzyme called NS5B polymerase, which builds new strands of the virus's genetic material. Sofosbuvir is a prodrug: liver cells convert it into an active form that looks like one of the building blocks the enzyme uses. When the enzyme picks it up, the strand cannot be extended, so the virus cannot make complete copies of itself. With copying blocked, the amount of virus in the blood falls quickly, and the body clears the infected cells over the course of treatment. Sofosbuvir is paired with a second antiviral that attacks the virus another way, which makes treatment more effective and makes it harder for the virus to develop resistance.

Dosage & Administration

For adults, Sovaldi is one 400 mg tablet taken by mouth once a day, with or without food. Children receive a weight-based dose, as a tablet or as oral pellets that come in packets and are prepared following the included instructions. How long treatment lasts depends on the genotype, earlier treatment and the state of the liver. Sovaldi regimens usually run 12 or 24 weeks, while the combination tablet Epclusa is usually taken for 12 weeks. Before starting, everyone has a blood test for hepatitis B. Take it every day at about the same time and finish the full course. Missing or skipping doses can make treatment less likely to cure the infection. If you are also taking ribavirin, its dose and timing are separate, and it is usually taken with food.

Side Effects

Tiredness and headache are the most common side effects when sofosbuvir is taken with ribavirin. Some people also have nausea, trouble sleeping, itching or irritability. Most of these are mild. Children most often have a reduced appetite. Much of what people feel depends on the partner drugs. Ribavirin can cause anemia (a low red blood cell count), which can add to tiredness or shortness of breath, so blood counts are checked. Regimens that include peginterferon cause more flu-like symptoms, fever, low blood counts and mood changes. Severe depression, including suicidal thoughts, has been reported rarely, mostly in people with a history of mental illness; new or worsening low mood is worth raising with the care team promptly.

Interactions & Warnings

Sovaldi carries an FDA boxed warning about hepatitis B. In people who have or once had hepatitis B, the hepatitis B virus can become active again during or after hepatitis C treatment, and some flares have caused liver failure and death. This is why everyone is tested for hepatitis B first, and people with evidence of it are monitored and may need hepatitis B treatment. Amiodarone, a medicine for irregular heart rhythms, can cause a dangerously slow heartbeat when taken with any sofosbuvir-containing treatment, sometimes within hours and up to two weeks after starting. The combination is not recommended, and anyone who must take both needs heart monitoring. Because amiodarone lasts a long time in the body, this also applies if it was stopped shortly before. Seek medical care immediately for fainting or near-fainting, dizziness, unusual weakness or tiredness, shortness of breath, chest pain or confusion. Some medicines make sofosbuvir less effective by lowering its levels. These include rifampin and related antibiotics used for tuberculosis, the herbal supplement St. John's wort, and the seizure medicines carbamazepine, phenytoin, phenobarbital and oxcarbazepine. They are not recommended together. As the infection clears and the liver works better, other medicines can behave differently. People with diabetes have had serious low blood sugar, and people taking warfarin, a blood thinner, may see their INR (a clotting test) change, so blood sugar or INR is checked more often and doses may be adjusted. Ribavirin can cause birth defects. When sofosbuvir is combined with ribavirin, the treatment must not be used during pregnancy or by men whose female partners are pregnant, and reliable contraception is needed. Tell the care team right away if a pregnancy happens.

What to Expect

Treatment is a set course of weeks, not a lifelong medicine. Many people feel little difference day to day, because chronic hepatitis C often causes few symptoms. Blood tests during treatment may check the virus, liver function and, with ribavirin, blood counts. Cure is confirmed with a blood test 12 weeks or more after the last dose. If the virus is undetectable then, the infection is considered cured. With current sofosbuvir combinations, cure rates in studies are very high; in one large trial of Epclusa, 99 percent of people had no detectable virus 12 weeks after finishing. If treatment does not work, a specialist can usually offer a different regimen. Cure does not protect against getting hepatitis C again, so people with ongoing exposure, such as shared drug-injection equipment, may be tested regularly. People who already had cirrhosis before treatment still need ongoing liver checks, including screening for liver cancer, even after cure.

Questions to Ask Your Doctor

  1. 1.Is Sovaldi with ribavirin the right choice for me, or would a combination tablet such as Epclusa be simpler and more effective?
  2. 2.How long will my treatment last, and which blood tests will I need during and after it?
  3. 3.Have I been tested for hepatitis B, and what happens if the test shows a current or past infection?
  4. 4.Could any of my medicines or supplements, especially heart rhythm, seizure, diabetes or blood-thinning medicines, interact with this treatment?
  5. 5.If ribavirin is part of my treatment, what contraception do my partner and I need, and for how long?

Last reviewed • Oct 2026

Educational content, not medical advice.